IRS Issues Final Rule Implementing Medical Device Excise Tax
The Internal Revenue Service released a
implementing a Patient Protection and Affordable Care Act provision that imposes on certain medical devices made after 2012 an excise tax equal to 2.3% of their sales price. In submitted on the proposed rule AHRMM, the American Hospital Association and others urged the IRS to explicitly prohibit device companies from passing the tax on to customers, and to clarify that hospitals and other healthcare providers who package and sterilize devices for use in surgery kits should not be treated as device manufacturers or importers under the rule. The final rule does not address AHRMM’s recommendation that manufacturers certify that the tax has not been passed on to customers, but provides that current rules apply in determining the sales price of items. Also, of importance, the final rule states that a kit produced by a hospital or medical institution for its own use would not be a taxable medical device.Related Resources
Advisory
AHRMM’s Issues & Legislative Committee issued the following Statement on Pricing Transparency approved by AHRMM Board of Directors:<
Issue Brief
This learning lab covers alarm safety management in the health care supply chain field.
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Supply Chain Strategies & Solutions Article
Supply chain must play an integral role in the care delivery process through cross-departmental partnerships that support evidence-based valu
As a Leading Practice, the AHRMM Board of Directors adopts that Supply Chain Services be fully integrated into high cost clinical services…